Voglinova 0.3mg Tablet
Marketer
TTK Healthcare Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglinova 0.3mg Tablet
DiaBeta 0.3mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated postprandial blood glucose. It's indicated when dietary modifications and other comparable medications prove insufficient in controlling hyperglycemia. DiaBeta 0.3mg should be administered immediately prior to meals. Dosage frequency is determined individually by your physician to optimize blood sugar control. Discontinuing this medication abruptly is unsafe and may lead to dangerously high blood sugar levels, potentially resulting in serious complications such as renal impairment or vision loss. This treatment is part of a comprehensive program encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Regular blood glucose monitoring is essential. Commonly reported side effects include intestinal gas, abdominal discomfort, decreased appetite, constipation, and diarrhea. Report any persistent or troubling side effects to your doctor. While DiaBeta 0.3mg alone doesn't induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your doctor of any existing liver or kidney conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all medications to your physician to ensure medication safety. Limit alcohol consumption while taking DiaBeta 0.3mg, as it can heighten the risk of hypoglycemia.
Uses of Voglinova 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Voglinova 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.3mg Voglinova tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
Common Side effects of Voglinova 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglinova 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Voglinova 0.3mg Tablets should be administered on an empty stomach.
How Voglinova 0.3mg Tablet works:
Glucovance 0.3mg tablets are used to manage diabetes. Their mechanism of action involves blocking intestinal enzymes that digest complex carbohydrates, thus mitigating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Voglinova 0.3mg tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Voglinova 0.3mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Based on available evidence, the use of 0.3mg Voglinova tablets while breastfeeding appears to pose minimal risk to the infant. Studies in humans indicate negligible harm to the nursing child.
DrivingSAFE
Driving ability is typically unaffected by Voglinova 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use 0.3mg Voglinova tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.3mg Voglinova tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglinova 0.3mg Tablet :
Omit any missed Voglinova 0.3mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglinova 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently